Showing results (71-80 of 126) with videos related to

Sort By:
Pageof 13
Cancer Cell International|December 5, 2021
Eribulin activity in soft tissue sarcoma monolayer and three-dimensional cell line models: could the combination with other drugs improve its antitumoral effect?Javier Escudero, Victoria Heredia-Soto, Yinyin Wang, et al.
Oncology Reports|July 25, 2012
Serum interleukin-15 levels in cancer patients with cachexiaPedro L Martínez-Hernández, Ángel Hernanz-Macías, Carmen Gómez-Candela, et al.
International Journal of Molecular Sciences|September 14, 2024
Cytokines and Pancreatic Ductal Adenocarcinoma: Exploring Their Relationship with Molecular Subtypes and PrognosisLaura Gutierrez-Sainz, Victoria Heredia-Soto, Ana Margarita Rodríguez-García, et al.
Journal of the National Cancer Institute|October 6, 2011
Development and validation of a prognostic nomogram for terminally ill cancer patientsJaime Feliu, Ana María Jiménez-Gordo, Rosario Madero, et al.
Molecular Cancer Therapeutics|July 2, 2014
Pharmacogenetic predictors of outcome in patients with stage II and III colon cancer treated with oxaliplatin and fluoropyrimidine-based adjuvant chemotherapyAna Custodio, Juan Moreno-Rubio, Jorge Aparicio, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|October 13, 2021
Prognostic implications of tumor-infiltrating T cells in early-stage endometrial cancerMarta Mendiola, Teijo Pellinen, Jorge L Ramon-Patino, et al.
Anticancer Research|September 9, 2018
Predicting Response to Standard First-line Treatment in High-grade Serous Ovarian Carcinoma by Angiogenesis-related GenesMarta Mendiola, Andrés Redondo, Victoria Heredia-Soto, et al.
ESMO Open|September 27, 2019
Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancerClaudia Cardone, Erika Martinelli, Teresa Troiani, et al.
Oncotarget|October 10, 2015
A link between lipid metabolism and epithelial-mesenchymal transition provides a target for colon cancer therapyRuth Sánchez-Martínez, Silvia Cruz-Gil, Marta Gómez de Cedrón, et al.
Cancers|January 23, 2024
Prevalence and Distribution of MUTYH Pathogenic Variants, Is There a Relation with an Increased Risk of Breast Cancer?Jesús Peña-López, Diego Jiménez-Bou, Icíar Ruíz-Gutiérrez, et al.
Pageof 13